Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial

Details 詳細情報について

• CRID

  1360574096344347392

• DOI

  10.1093/annonc/mdw611

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419322227?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419322227?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/28/2/270/24169081/mdw611.pdf

• Data Source

  • Crossref